Roche (RHHBY) expects an increase in Group sales in the mid single digit range CER for 2026. Core earnings per share are targeted to develop in the high single digit range CER. Roche expects to further increase its dividend in Swiss francs.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Genentech announces topline results from CT388-103 trial
- Roche initiated with a Buy at Citi
- NVDA, GOOGL, AMZN: Trump’s Greenland Gambit Rattles Big Tech as EU Weighs Salvo
- Genentech to more than double East Coast manufacturing plant investment to $2B
- Novartis Stock (NVS) Holds on Upbeat View of Tariff Exposure amid U.S.-EU Tension